Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

PIRS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.39%

Insider Buying (Last 12 Months): $92,311.00

Insider Selling (Last 12 Months): $0.00

Pieris Pharmaceuticals Insider Trading History Chart

Pieris Pharmaceuticals Share Price & Price History

^$13.60

▼ -2.53 (-15.69%)

As of 12/13/2024 05:00 PM ET

Days: 30 | 90 | 365

URGENT: This Altcoin Opportunity Won’t Wait – Act Now

From Crypto Swap Profits | Ad

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Pieris Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/12/2024	Adar1 Capital Management, Llc	Major Shareholder	Buy	3,000	$15.88	$47,640.00	129,574
8/9/2024	Adar1 Capital Management, Llc	Major Shareholder	Buy	3,000	$14.89	$44,670.00	127,331
8/7/2024	James A Geraghty	Director	Buy	1	$1.00	$1.00	1
5/25/2023	Christopher P Kiritsy	Director	Buy	125	$68.00	$8,500.00	250
5/13/2022	Tim Demuth	Insider	Buy	75	$136.80	$10,260.00	75

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

SEC Filings (Institutional Ownership Changes) for Pieris Pharmaceuticals (NASDAQ:PIRS)

40.11% of Pieris Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Pieris Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/15/2024	Frazier Life Sciences Management L.P.	15,942	$0.27M	0.0%	N/A	1.208%
11/5/2024	BML Capital Management LLC	42,130	$0.70M	0.4%	N/A	3.192%
8/15/2024	Lynx1 Capital Management LP	43,499	$0.43M	0.2%	-99.5%	3.295%
8/9/2024	Renaissance Technologies LLC	11,471	$0.11M	0.0%	-99.2%	0.869%
8/6/2024	Acadian Asset Management LLC	10,827	$0.11M	0.0%	-98.9%	0.820%
5/30/2024	Lynx1 Capital Management LP	8,779,162	$1.61M	0.4%	-10.2%	665.088%
5/14/2024	CM Management LLC	575,000	$0.11M	0.1%	-23.3%	46.483%
4/23/2024	Summit Trail Advisors LLC	140,000	$26K	0.0%	N/A	0.142%
11/13/2023	Acadian Asset Management LLC	962,358	$0.29M	0.0%	+64.8%	0.974%
11/7/2023	CM Management LLC	649,400	$0.19M	0.2%	+18.1%	0.657%
8/15/2023	Silverarc Capital Management LLC	961,338	$0.16M	0.0%	N/A	0.973%
8/15/2023	BVF Inc. IL	20,609,863	$3.41M	0.1%	+305.7%	20.850%
8/7/2023	Acadian Asset Management LLC	584,019	$96K	0.0%	-7.4%	0.712%
8/4/2023	CM Management LLC	550,000	$91K	0.1%	N/A	0.671%
5/15/2023	Affinity Asset Advisors LLC	306,950	$0.30M	0.1%	N/A	0.374%
5/12/2023	Platinum Investment Management Ltd.	975,012	$0.95M	0.0%	-20.1%	1.308%
5/11/2023	Acadian Asset Management LLC	630,690	$0.62M	0.0%	-28.5%	0.846%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	70,231	$69K	0.0%	-37.9%	0.094%
3/15/2023	B. Riley Wealth Advisors Inc.	34,000	$35K	0.0%	-34.1%	0.046%
2/13/2023	GSA Capital Partners LLP	365,047	$0.38M	0.0%	N/A	0.491%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	113,078	$0.12M	0.0%	-15.4%	0.152%
2/3/2023	Cutter & CO Brokerage Inc.	378,479	$0.39M	0.1%	-6.9%	0.509%
2/1/2023	Bank of Montreal Can	481,727	$0.50M	0.0%	N/A	0.647%
1/24/2023	Sigma Planning Corp	343,934	$0.36M	0.0%	+9.0%	0.462%
11/15/2022	Platinum Investment Management Ltd.	1,220,798	$1.40M	0.1%	+11.1%	1.641%
11/14/2022	Annandale Capital LLC	50,000	$58K	0.0%	N/A	0.067%
11/14/2022	Lynx1 Capital Management LP	3,515,140	$4.04M	3.6%	+9.1%	4.724%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	133,662	$0.15M	0.0%	+51.0%	0.180%
8/12/2022	Rafferty Asset Management LLC	29,622	$55K	0.0%	+32.3%	0.040%
8/11/2022	Sigma Planning Corp	315,384	$0.59M	0.0%	-12.6%	0.424%
8/11/2022	Bank of Montreal Can	789,500	$2.60M	0.0%	N/A	1.061%
8/11/2022	Platinum Investment Management Ltd.	1,098,888	$2.06M	0.1%	+6.9%	1.477%
8/10/2022	Mackenzie Financial Corp	13,649	$26K	0.0%	N/A	0.018%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	88,502	$0.17M	0.0%	-41.2%	0.119%
7/28/2022	Cutter & CO Brokerage Inc.	412,229	$0.77M	0.3%	+1.5%	0.556%
5/17/2022	Great Point Partners LLC	2,199,076	$6.66M	1.6%	+41.9%	2.968%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	150,492	$0.46M	0.0%	-42.0%	0.203%
5/9/2022	Commerce Bank	20,000	$61K	0.0%	N/A	0.027%
5/3/2022	Cutter & CO Brokerage Inc.	406,229	$1.23M	0.4%	+2.9%	0.548%
4/25/2022	Bailard Inc.	19,600	$59K	0.0%	N/A	0.026%
4/25/2022	Assenagon Asset Management S.A.	1,208,226	$3.66M	0.0%	-18.1%	1.631%
2/19/2022	Woodline Partners LP	2,463,641	$9.31M	0.1%	N/A	3.419%
2/15/2022	Lynx1 Capital Management LP	383,266	$1.45M	1.3%	N/A	0.532%
2/14/2022	Soleus Capital Management L.P.	687,412	$2.60M	0.3%	-7.1%	0.954%
2/14/2022	Blair William & Co. IL	117,985	$0.45M	0.0%	+686.6%	0.164%
2/10/2022	Qube Research & Technologies Ltd	24,883	$94K	0.0%	N/A	0.035%
2/10/2022	Cutter & CO Brokerage Inc.	394,800	$1.49M	0.4%	+21.1%	0.548%
2/10/2022	Rafferty Asset Management LLC	20,547	$78K	0.0%	-35.4%	0.029%
2/10/2022	Citigroup Inc.	492,494	$1.86M	0.0%	+3.9%	0.683%
2/10/2022	Acadian Asset Management LLC	347,243	$1.31M	0.0%	+380.0%	0.482%
2/10/2022	OLD Mission Capital LLC	70,092	$0.27M	0.0%	N/A	0.097%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	259,670	$0.98M	0.0%	+4.6%	0.360%
2/9/2022	BNP Paribas Arbitrage SA	250,219	$0.95M	0.0%	+29,546.8%	0.347%
2/9/2022	Wealth Effects LLC	87,300	$0.33M	0.1%	N/A	0.121%
2/7/2022	SG Americas Securities LLC	18,400	$70K	0.0%	N/A	0.026%
2/2/2022	Sigma Planning Corp	359,234	$1.36M	0.0%	-1.4%	0.499%
2/1/2022	Assenagon Asset Management S.A.	1,475,778	$5.58M	0.0%	+358.0%	2.048%
2/1/2022	Qube Research & Technologies Ltd	24,883	$94K	0.0%	N/A	0.035%
11/16/2021	Cetera Advisors LLC	10,100	$52K	0.0%	N/A	0.014%
11/16/2021	Squarepoint Ops LLC	35,592	$0.18M	0.0%	-72.5%	0.049%
11/16/2021	Two Sigma Advisers LP	1,114,700	$5.76M	0.0%	N/A	1.547%
11/16/2021	Two Sigma Investments LP	1,167,548	$6.04M	0.0%	N/A	1.620%
11/16/2021	Millennium Management LLC	2,046,850	$10.58M	0.0%	-30.7%	2.840%
11/15/2021	Cubist Systematic Strategies LLC	432,289	$2.24M	0.0%	+913.7%	0.600%
11/15/2021	Marshall Wace LLP	219,428	$1.13M	0.0%	+975.2%	0.304%
11/15/2021	Invesco Ltd.	1,501,699	$7.76M	0.0%	N/A	2.084%
11/12/2021	Renaissance Technologies LLC	300,851	$1.56M	0.0%	-62.9%	0.417%
11/12/2021	Jump Financial LLC	87,831	$0.45M	0.0%	N/A	0.122%
11/12/2021	Hsbc Holdings PLC	13,213	$70K	0.0%	N/A	0.018%
11/12/2021	Credit Suisse AG	68,940	$0.36M	0.0%	-10.1%	0.096%
11/12/2021	Geode Capital Management LLC	693,696	$3.59M	0.0%	+21.2%	0.963%
11/12/2021	B. Riley Wealth Management Inc.	33,000	$0.17M	0.0%	N/A	0.046%
11/12/2021	Connor Clark & Lunn Investment Management Ltd.	248,308	$1.28M	0.0%	N/A	0.345%
11/10/2021	Goldman Sachs Group Inc.	498,581	$2.58M	0.0%	+2,240.3%	0.692%
11/10/2021	Citigroup Inc.	473,816	$2.45M	0.0%	+14.6%	0.658%
11/10/2021	Rafferty Asset Management LLC	31,796	$0.16M	0.0%	N/A	0.044%
11/9/2021	Barclays PLC	40,339	$0.21M	0.0%	+523.0%	0.056%
11/9/2021	BlackRock Inc.	1,276,990	$6.60M	0.0%	-2.0%	1.772%
11/9/2021	Platinum Investment Management Ltd.	1,028,322	$5.32M	0.1%	-11.7%	1.427%
11/2/2021	Cutter & CO Brokerage Inc.	326,100	$1.69M	0.4%	N/A	0.489%
10/28/2021	Sigma Planning Corp	364,484	$1.88M	0.1%	+1.3%	0.546%
10/28/2021	Truepoint Inc.	10,000	$52K	0.0%	N/A	0.015%
10/19/2021	Assenagon Asset Management S.A.	322,241	$1.67M	0.0%	+8.0%	0.483%
8/26/2021	Y Intercept Hong Kong Ltd	10,867	$42K	0.0%	N/A	0.016%
8/25/2021	Marshall Wace LLP	20,409	$78K	0.0%	N/A	0.031%
8/17/2021	Millennium Management LLC	2,952,631	$11.31M	0.0%	N/A	4.426%
8/17/2021	BVF Inc. IL	5,328,239	$20.41M	0.8%	-3.0%	7.987%
8/16/2021	Squarepoint Ops LLC	129,608	$0.50M	0.0%	N/A	0.194%
8/16/2021	LMR Partners LLP	23,158	$89K	0.0%	N/A	0.035%
8/16/2021	Point72 Asset Management L.P.	1,000,000	$3.83M	0.0%	N/A	1.499%
8/16/2021	Cubist Systematic Strategies LLC	42,643	$0.16M	0.0%	N/A	0.064%
8/16/2021	Morgan Stanley	1,675,969	$6.42M	0.0%	+104.6%	2.512%
8/16/2021	Credit Suisse AG	76,683	$0.29M	0.0%	-5.9%	0.115%
8/16/2021	Schonfeld Strategic Advisors LLC	10,980	$42K	0.0%	N/A	0.016%
8/16/2021	Charles Schwab Investment Management Inc.	19,437	$75K	0.0%	-85.8%	0.029%
8/16/2021	State Street Corp	170,087	$0.65M	0.0%	-81.5%	0.255%
8/16/2021	Tibra Equities Europe Ltd	65,400	$0.25M	0.1%	N/A	0.098%
8/16/2021	Marshall Wace LLP	20,409	$78K	0.0%	N/A	0.031%
8/13/2021	Renaissance Technologies LLC	811,190	$3.11M	0.0%	-39.0%	1.216%
8/13/2021	Alpine Global Management LLC	10,800	$41K	0.0%	N/A	0.016%

Data available starting January 2016

Pieris Pharmaceuticals, Inc., a biotechnology company, discovers and develops biotechnological applications. The company focuses on the development of its 4-1BB bispecifics immuno-oncology (IO) programs. Its clinical pipeline consists of IO bispecifics, including S095012 (PRS-344), a bispecific Mabcalin compound targeting PD-L1 and 4-1BB in partnership with Les Laboratoires Servier and Institut de Recherches Internationales Servier; SGN-BB228 (PRS-346), a CD228 x 4-1BB bispecific antibody-Anticalin compound targeting CD228 and 4-1BB in partnership with Pfizer Inc.; and BOS-342 (PRS-342), a GPC3 x 4-1BB bispecific Mabcalin compound targeting GPC3 and 4-1BB in partnership with Boston Pharmaceuticals, which are in phase 1 studies. The company was founded in 2001 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $13.60

$13.26

$15.35

50 Day Range

MA: $16.20

$13.60

$17.30

52 Week Range

Now: $13.60

$6.20

$22.32

Volume

51,700 shs

Average Volume

45,988 shs

Market Capitalization

$17.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.61

Who are the company insiders with the largest holdings of Pieris Pharmaceuticals?: Pieris Pharmaceuticals' top insider investors include:
Adar1 Capital Management, Llc (Major Shareholder)
Christopher P Kiritsy (Director)
James A Geraghty (Director)
Learn More about top insider investors at Pieris Pharmaceuticals.
Who are the major institutional investors of Pieris Pharmaceuticals?: Pieris Pharmaceuticals' top institutional investors include:
BML Capital Management LLC — 3.19%
Frazier Life Sciences Management L.P. — 1.21%
Learn More about top institutional investors of Pieris Pharmaceuticals stock.
Which institutional investors are buying Pieris Pharmaceuticals stock?: During the last quarter, PIRS stock was acquired by institutional investors including:
BML Capital Management LLC
Frazier Life Sciences Management L.P.
In the previous year, these company insiders have bought Pieris Pharmaceuticals stock:
Adar1 Capital Management, Llc (Major Shareholder)
Christopher P Kiritsy (Director)
James A Geraghty (Director)
Learn More investors buying Pieris Pharmaceuticals stock.

First JFK… next Elon?

From Porter & Company | Ad